Brief: NexImmune Reports First Quarter 2022 Financial Results And Provides Business Updates
12/05/2022 21:55
May 12 (Reuters) - Neximmune Inc NEXI.O :
* NEXIMMUNE REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES BUSINESS UPDATES
* Q1 GAAP LOSS PER SHARE $0.66
* NEXIMMUNE - EXPECTS EXISTING CASH, CASH EQUIVALENTS,
MARKETABLE
SECURITIES TO ENABLE TO FUND OPERATING, CAPEX REQUIREMENTS INTO
Q2 OF 2023
Source text for Eikon: ID:nGNX367zFs
Further company coverage: NEXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Neximmune
See all newsBrief: Neximmune Appointed Albert Marchio As Interim CFO
Brief: NexImmune and Agents Agreed To Terminate Sales Agreement & ATM Program dated June 2022
Brief: NexImmune Says Co Expects Existing Cash And Cash Equivalents Will Be Sufficient To Meet Its Anticipated Cash Requirements Through Mid-February 2024
Brief: Neximmune Gets Notice From Listing Qualifications Department Of Nasdaq
Brief: NexImmune Announces Presentations at The Society for Immunotherapy of Cancer’s 38th Annual Meeting